📋 Indications & Clinical Dosage
*Type 2 diabetes not controlled by metformin alone, particularly in obese:*
Adult: 1 tablet twice daily, titration with the individual components (pioglitazone and metformin) desirable before initiation
Children: Not recommended.
⛔ Contraindications
History of heart failure, previous or active bladder cancer, severe infection, shock, trauma, uninvestigated haematuria, dialysis, diabetic ketoacidosis, pregnancy and lactation.
⚠️ Precautions & Warnings
Porphyrias, monitor for fluid retention or other signs of cardiac failure (discontinue if deteriorates). Monitor for risk factors for lactic acidosis. Monitor for weight gain and anaemia. Withdraw 48 hours before elective surgery. Monitor for signs of hepatic dysfunction and check liver enzymes prior to therapy and every 2 months thereafter, elderly, risk of bone fracture and bladder cancer particularly in women and elderly.
🔄 Drug Interactions
Insulin (contraindicated), NSAIDs, gemfibrozil, rifampicin.
Insulin, gemfibrozil, rifampicin, NSAIDs, intravascular iodinated contrast media, alcohol, cimetidine, cocorticosteroids, beta2-agonists, diuretics, ACE inhibitors,
⚠️ Adverse Reactions / Side Effects
GI disturbances, anaemia, arthralgia, dizziness, haematuria, headache, hypoaesthesia, impotence, oedema, vertigo, visual disturbances, weight gain, altered blood lipids, bladder cancer, fatigue, hypoglycaemia, insomnia, proteinuria, sweating, rare; liver dysfunction.
🤰 Pregnancy & Lactation Safety
Pregnancy Risk:
Contraindicated or not recommended
Lactation / Breastfeeding:
Contraindicated or not recommended.
📚 Official Regulatory & Clinical References
- Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
- World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
- Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.